Book a free demo
H-1B Data › Employers › Takeda Pharmaceuticals USA, Inc.
Check another employer
H-1B Sponsor Profile

Takeda Pharmaceuticals USA, Inc. — H-1B Visa Sponsorship Data

205 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.

Lexington, MAActive FY2021–FY2026Transfer-FriendlyFull-Time RolesNot H-1B Dependent
● Data current through FY2026 · sourced from U.S. DOL OFLC, updated quarterly
Sponsors H-1B?
Yes
205 certified LCAs
FY2026 filings
22
most recent disclosure year
Median H-1B salary
$165,000
typical $145,000–$185,000
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
52%
change-of-employer filings

3 items a DOL auditor would ask Takeda Pharmaceuticals USA, Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Takeda Pharmaceuticals USA, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.

2 need attention1 to watch3 clear
Needs attention
10 certified LCAs (10 positions) end within 180 days

Next end date: 2026-10-14. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.

Auditor asksWhich workers are on each expiring LCA, and is a superseding LCA already certified?
In your PAFSuperseding LCA, updated PAF entry and new posting notice for every position that continues.
Needs attention
16 worksites across 7 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Watch
21% of LCAs denied or withdrawn (FY2024–FY2026)

Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.

Auditor asksWere the workers on withdrawn LCAs re-covered by a valid certified LCA before continuing work?
In your PAFWithdrawal acknowledgements; superseding LCAs; PAF entries showing the transition.
Clear
4% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
5% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 16% above the DOL prevailing wage across 88 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you Takeda Pharmaceuticals USA, Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at Takeda Pharmaceuticals USA, Inc.?

Does Takeda Pharmaceuticals USA, Inc. sponsor H-1B visas?

Yes — Takeda Pharmaceuticals USA, Inc. is an active H-1B sponsor, with 205 certified LCAs on file (FY2021–FY2026), including 22 in FY2026. The median certified salary is $165,000 (P25 $145,000, P75 $185,000). With a 52% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to Takeda Pharmaceuticals USA, Inc.

Salary range
Median $165,000, typical band $145,000–$185,000.
Transfers
52% of filings are transfers — this employer has an established H-1B transfer track record.
Typical locations
Cambridge, MA, Lexington, MA, Bannockburn, IL, Exton, PA.
Position type
99.6% of filings are full-time roles.
Common roles
Associate Director, Omnichannel Engage, Product Manager, Development And Medic, Quality Control Manager.
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. Takeda Pharmaceuticals USA, Inc. has 205 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2026).

The median sponsored salary is $165,000, with a typical P25–P75 band of $145,000–$185,000 across certified LCAs.

Yes — 52% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

No — the employer attests it is not H-1B dependent on its LCA filings.

Takeda Pharmaceuticals USA, Inc. filed 22 certified LCAs in FY2026, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include Cambridge, MA, Lexington, MA, Bannockburn, IL, Exton, PA.
Sponsorship data

Takeda Pharmaceuticals USA, Inc. H-1B data at a glance

Executive Summary

Takeda Pharmaceuticals USA, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).

  • Median certified salary is $165,000, typically $145,000–$185,000 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 52% — workers actively transfer to this employer.
  • Worksite footprint spans 7 states and 16 cities.
  • Most-sponsored roles: Associate Director, Omnichannel Engageme, Product Manager, Development And Medical, Quality Control Manager.
  • Filed 22 certified LCAs in FY2026, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$72,000
$370,800
P25$145,000
Median$165,000
P75$185,000

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
4%
Level II
17%
Level III
25%
Level IV
54%

Levels I–IV are DOL prevailing-wage experience tiers; 79% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
34
FY2022
41
FY2023
42
FY2024
35
FY2025
31
FY2026
22
Fiscal yearCertifiedDeniedWithdrawnTotal
FY2021340135
FY2022410546
FY2023420951
FY2024350742
FY20253101546
FY2026220224

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2024 ›FY2025 ›FY2026 ›

All LCA filings

Latest 200 of 244 on record
Job titleSalaryLevelLocationFiledStatus
System Architect - Product Engineer
I-200-26138-924188
$202,942/yrIVCambridge, MAMay 18, 2026Certified
Operations Support Specialist
I-200-26133-907399
$135,015/yrIIIBannockburn, ILMay 13, 2026Certified
Manager, US Medical Information Lead Neuroscience
I-200-26127-884178
$150,000/yrIIILexington, MAMay 07, 2026Certified
Analytics Project Lead
I-200-26125-871829
$123,360/yrIIICambridge, MAMay 05, 2026Certified
Oncology Business Unit DDT Business Partner, MA
I-200-26124-865716
$220,000/yrIIICambridge, MAMay 04, 2026Certified
PDT DDT Systems Manager
I-200-26121-859949
$163,881/yrIVBannockburn, ILMay 01, 2026Certified
Data Science Engineer
I-200-26120-856273
$173,775/yrIIILexington, MAApr 30, 2026Certified
Head of DD&T, Strategic Planning & Program Excellence
I-200-26093-757015
$255,000/yrIVCambridge, MAApr 03, 2026Certified
Product Engineer
I-200-26086-735390
$147,114/yrIIIBannockburn, ILMar 27, 2026Certified
Technology Lead - Quality Systems
I-200-26072-702929
$188,977/yrIIILexington, MAMar 13, 2026Certified
Head of Enterprise Strategy Enablement, Commercial
I-200-26041-630517
$235,067/yrIIICambridge, MAFeb 10, 2026Certified
Quality Control Manager
I-200-26008-545853
$146,789/yrIILexington, MAJan 08, 2026Certified
Product Manager
I-200-25352-495420
$188,781/yrIICambridge, MADec 18, 2025Certified
Director, GPD DDT Medical GI TA
I-200-25352-494055
$225,000/yrIIICambridge, MADec 18, 2025Certified
Network Platform Owner – LAN and Automation
I-200-25335-447592
$182,000/yrIVLeander, TXDec 01, 2025Certified
USBU DD&T Data Products and Services Lead
I-200-25330-440741
$225,570/yrIIICambridge, MANov 26, 2025Certified
Senior Manager, IBD Analytics
I-200-25329-435867
$162,552/yrIVCambridge, MANov 25, 2025Certified
Service Governance Lead
I-200-25324-425297
$207,517/yrIILexington, MANov 20, 2025Certified
Platform Architect
I-200-25310-382198
$170,000/yrIVCambridge, MANov 06, 2025Certified
Brand Insights and Analytics Lead, US Oncology
I-200-25309-378104
$190,000/yrIVCambridge, MANov 05, 2025Certified
Assoc. Dir., Sci. & Competitive Analysis, Glbl Oncology
I-200-25273-345047
$190,000/yrICambridge, MASep 30, 2025Certified
DDT Engineer Strategy & Business Excellence
I-200-25273-348795
$169,365/yrIIILexington, MASep 30, 2025Certified
Global Digital Health Technical Product Owner
I-200-25247-285461
$180,250/yrIICambridge, MASep 03, 2025Certified
Global Digital Health Technical Product Owner
I-200-25247-285443
$180,250/yrIVCambridge, MASep 03, 2025Withdrawn
Head of Platform Delivery
I-200-25241-277134
$211,967/yrIIICambridge, MAAug 29, 2025Certified

See all of Takeda Pharmaceuticals USA, Inc.'s filings in the H-1B explorer →

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How Takeda Pharmaceuticals USA, Inc. sponsors H-1B talent

Petition Mix

New employment  9%Transfer (change of employer)  52%Continued employment  23%Amendments & other  16%
High transfer share (52%) — H-1B workers actively change employers to join Takeda Pharmaceuticals USA, Inc..

Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Jun and May — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
99.6%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Associate Director, Omnichannel En
4 · $189,991
Product Manager, Development And M
4 · $180,745
Quality Control Manager
4 · $138,246
Test Architect
4 · $156,372
Data Engineer– Sap Bw (Gmsgq)
3 · $150,000

Top worksite locations

7 states · 16 cities

Cambridge, MA
117
Lexington, MA
70
Bannockburn, IL
21
Exton, PA
21
Westborough, MA
3
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore more

Similar H-1B sponsors by filing volume

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
Takeda Pharmaceuticals USA, Inc. · audit readiness
2 need attention1 to watch3 clear
Get my private gap check →